Newcastle University Business School, Citywall, Citygate, Newcastle Upon Tyne, United Kingdom.
Stem Cells Transl Med. 2012 May;1(5):438-47. doi: 10.5966/sctm.2011-0009. Epub 2012 May 9.
We identify three dimensions with which to classify heuristically the routes to widespread adoption of cellular therapies. The first dimension is based on the relative involvement of clinicians and companies in a particular cellular therapy. The second dimension is based on cell type and consequent scale of manufacture. The third dimension classifies the therapeutic intervention as a procedure or product and has perhaps received less attention. We suggest that for those cellular therapies that require therapeutic procedures, close collaboration between companies and clinicians will reduce the time to widespread adoption. For selected cellular therapies we make predictions of the likely time to widespread adoption.
我们确定了三个维度，可以对细胞疗法广泛应用的途径进行启发式分类。第一个维度基于临床医生和公司在特定细胞疗法中的相对参与程度。第二个维度基于细胞类型和随后的制造规模。第三个维度将治疗干预分为程序或产品，可能受到的关注较少。我们认为，对于那些需要治疗程序的细胞疗法，公司和临床医生之间的密切合作将缩短广泛采用的时间。对于某些选定的细胞疗法，我们对广泛采用的可能时间进行了预测。
